Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q2 2024 Earnings Call Transcript
Operator: Hello, and thank you for joining the Zevra Therapeutics Q2 2024 Financial Results and Corporate Highlights Call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,419,435 | $11,855,232 | -2% | 0.69% |
2. | Altium Capital Jacob Gottlieb | 1,162,416 | $5,695,838 | +241% | 2.32% |
3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,147,583 | $5,623,157 | +14% | 0.05% |
4. | 683 Capital Partners Ari Zweiman | 800,000 | $3,920,000 | 0.29% | |
5. | AIGH Investment Partners Orin Hirschman | 181,673 | $890,197 | 0.27% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$6.77 | 2,000 | Officer | 18,469 | 2024-07-17 | Filing | |
$6.81 | 10,000 | Director | 20,000 | 2024-07-16 | Filing | |
$5.87 | 10,000 | Director | 30,000 | 2024-07-12 | Filing | |
$5.13 | 500 | Officer | 3,500 | 2023-09-05 | Filing | |
$4.96 | 1,000 | Officer | 15,309 | 2023-09-06 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 2,410,289 | $15,787,393 | 0% | |
2. | 1,645,140 | $10,775,667 | 0% | |
3. | 729,179 | $4,776,597 | 0% | |
4. | 636,060 | $4,166,193 | 0% | |
5. | 387,427 | $2,537,647 | 1.14% |